ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Replimune Group Inc

Replimune Group Inc (REPL)

12,62
0,06
(0,48%)
Fermé 04 Janvier 10:00PM
12,62
0,01
(0,08%)
Après les heures de négociation: 12:00AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
12,62
Prix Achat
11,08
Prix Vente
12,65
Volume échangé
528 731
12,36 Fourchette du Jour 12,81
4,92 Plage de 52 semaines 16,52
Cap du marché
Clôture Veille
12,56
Ouverture
12,69
Dernière Transaction
6118
@
12.62
(priorref)
Dernière heure de transaction
Volume financier
US$ 6 649 120
VWAP
12,5756
Volume moyen (3 m)
781 736
Actions en circulation
68 417 444
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,00
Bénéfice par action (BPA)
-3,15
Chiffre d'affairess
-
Bénéfice net
-215,79M

À propos de Replimune Group Inc

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex v... Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
Replimune Group Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker REPL. Le dernier cours de clôture d'Replimune était de US$12,56. Au cours de la dernière année, les actions de Replimune ont été négociées dans une fourchette de prix de US$ 4,92 à US$ 16,52.

Replimune compte actuellement 68 417 444 actions en circulation. La capitalisation boursière d'Replimune est de US$859,32 million. Replimune a un ratio cours/bénéfice (ratio PE) de -4.00.

REPL Dernières nouvelles

Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WOBURN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...

Replimune Announces Pricing of Upsized Public Offering

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...

Replimune Announces Proposed Public Offering

WOBURN, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.020.1587301587312.613.5611.9370888412.34567322CS
4-0.48-3.664122137413.113.5611.1974809112.36315665CS
121.5614.104882459311.0616.529.9478173612.6885256CS
264.1248.47058823538.516.527.8673395211.58108692CS
523.7742.59887005658.8516.524.9210345009.16961948CS
156-14.62-53.67107195327.2430.894.9272927413.14447344CS
260-1.78-12.361111111114.454.854.9255992117.72265596CS

REPL - Frequently Asked Questions (FAQ)

What is the current Replimune share price?
The current share price of Replimune is US$ 12,62
How many Replimune shares are in issue?
Replimune has 68 417 444 shares in issue
What is the market cap of Replimune?
The market capitalisation of Replimune is USD 859,32M
What is the 1 year trading range for Replimune share price?
Replimune has traded in the range of US$ 4,92 to US$ 16,52 during the past year
What is the PE ratio of Replimune?
The price to earnings ratio of Replimune is -4
What is the reporting currency for Replimune?
Replimune reports financial results in USD
What is the latest annual profit for Replimune?
The latest annual profit of Replimune is USD -215,79M
What is the registered address of Replimune?
The registered address for Replimune is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Replimune website address?
The website address for Replimune is www.replimune.com
Which industry sector does Replimune operate in?
Replimune operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées